tofacitinib vitiligo

Tofacitinib Citrate (540737-29-9) Tofacitinib citrate is a Janus kinase inhibitor marketed under the trade name Xeljanz. It is indicated for the treatment of severe active rheumatoid arthritis (RA) in adult patients who have had an inadequate response to or intolerance of methotrexate. Product Specifications Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C22 H28 N6 O8 Molecular Weight: 504.50